---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-106404"
form_type: "8-K"
ticker: "HUMA"
cik: "0001818382"
company_name: "Humacyte, Inc."
filed_at: "2024-10-07T23:59:59+00:00"
generated_at: "2026-05-30T19:26:21.017535+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Humacyte prices $30M registered direct offering of common stock and warrants at $5.28/unit

## Summary
- Offering of 5,681,820 common shares and 5,681,820 warrants at $5.28 per unit.
- Gross proceeds approximately $30M before fees and expenses.
- Warrants split: 2,840,910 expire in 6 months; 2,840,910 expire in 4.5 years; exercise price $5.28 each.
- Expected to close October 7, 2024; EF Hutton acting as placement agent with 6% fee plus expense cap.
- Offered under effective shelf registration statement on Form S-3 (File No. 333-267225).

## SEC filing metadata
- accession: 0001104659-24-106404
- form_type: 8-K
- ticker: HUMA
- cik: 0001818382
- company_name: Humacyte, Inc.
- filed_at: 2024-10-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818382/000110465924106404/0001104659-24-106404-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818382/000110465924106404/tm2425697d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-106404
- JSON: https://secwatch.observer/filing/0001104659-24-106404.json
- Plain text: https://secwatch.observer/filing/0001104659-24-106404.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.